Journal of Comprehensive Pediatrics

Published by: Kowsar

A Randomized Trial Comparing Surfactant Administration Using InSurE Technique and the Minimally Invasive Surfactant Therapy in Preterm Infants (28 to 34 Weeks of Gestation) with Respiratory Distress Syndrome

Ziba Mosayebi 1 , Maliheh Kadivar 1 , Nima Taheri-Derakhsh 2 , Shahin Nariman 2 , Sayed Mahdi Marashi 3 and Zohreh Farsi 2 , *
Authors Information
1 Department of Neonatology, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Neonatology, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Journal of Comprehensive Pediatrics: November 2017, 8 (4); e60724
  • Published Online: November 30, 2017
  • Article Type: Research Article
  • Received: August 22, 2017
  • Accepted: September 25, 2017
  • DOI: 10.5812/compreped.60724

To Cite: Mosayebi Z, Kadivar M, Taheri-Derakhsh N, Nariman S, Mahdi Marashi S, et al. A Randomized Trial Comparing Surfactant Administration Using InSurE Technique and the Minimally Invasive Surfactant Therapy in Preterm Infants (28 to 34 Weeks of Gestation) with Respiratory Distress Syndrome, J Compr Ped. 2017 ; 8(4):e60724. doi: 10.5812/compreped.60724.

Copyright © 2017, Journal of Comprehensive Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Chong E, Greenspan J, Kirkby S, Culhane J, Dysart K. Changing use of surfactant over 6 years and its relationship to chronic lung disease. Pediatrics. 2008;122(4):917-21. doi: 10.1542/peds.2007-3193. [PubMed: 18824498].
  • 2. Hamvas AMR, Fanaroff AA, Walsh MC. Pathophysiology and management of respiratory distress syndrome fanaroff and martins neonatal perinatal medicine. 9 ed. St. Louis, United States: Elsevier Mosby; 2011.
  • 3. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959;97(5, Part 1):517-23. [PubMed: 13649082].
  • 4. Saker F, Martin R. Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn. Waltham, United States: UpToDate; 2013. Available from:
  • 5. Bae CW, Hahn WH. Surfactant therapy for neonatal respiratory distress syndrome: a review of Korean experiences over 17 years. J Korean Med Sci. 2009;24(6):1110-8. doi: 10.3346/jkms.2009.24.6.1110. [PubMed: 19949668].
  • 6. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;(4):3063. doi: 10.1002/14651858.CD003063.pub3. [PubMed: 17943779].
  • 7. Odonnell CP, Kamlin CO, Davis PG, Morley CJ. Endotracheal intubation attempts during neonatal resuscitation: success rates, duration, and adverse effects. Pediatrics. 2006;117(1):16-21. doi: 10.1542/peds.2005-0901. [PubMed: 16396845].
  • 8. Kumar P, Denson SE, Mancuso TJ, Committee on F, Newborn SOA, Pain M. Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics. 2010;125(3):608-15. doi: 10.1542/peds.2009-2863. [PubMed: 20176672].
  • 9. Polin RA, Sahni R. Newer experience with CPAP. Semin Neonatol. 2002;7(5):379-89. [PubMed: 12464500].
  • 10. Pfister RH, Soll RF. Initial respiratory support of preterm infants: the role of CPAP, the INSURE method, and noninvasive ventilation. Clin Perinatol. 2012;39(3):459-81. doi: 10.1016/j.clp.2012.06.015. [PubMed: 22954263].
  • 11. Kamper J. Early nasal continuous positive airway pressure and minimal handling in the treatment of very-low-birth-weight infants. Biol Neonate. 1999;76 Suppl 1:22-8. doi: 10.1159/000047043. [PubMed: 10393390].
  • 12. Bohlin K, Bouhafs RK, Jarstrand C, Curstedt T, Blennow M, Robertson B. Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits. Pediatr Res. 2005;57(5 Pt 1):624-30. doi: 10.1203/01.PDR.0000156502.84909.BC. [PubMed: 15718361].
  • 13. Aguar M, Vento M, Dargaville PA. Minimally invasive surfactant therapy, an update. NeoReviews. 2014;15(7):275-85. doi: 10.1542/neo.15-7-e275.
  • 14. Dani C, Berti E, Barp J. Risk factors for INSURE failure in preterm infants. Minerva Pediatr. 2010;62(3 Suppl 1):19-20. [PubMed: 21089712].
  • 15. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed. 2011;96(4):243-8. doi: 10.1136/adc.2010.192518. [PubMed: 20971722].
  • 16. Aguar M, Cernada M, Brugada M, Gimeno A, Gutierrez A, Vento M. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies. Acta Paediatr. 2014;103(6):229-33. doi: 10.1111/apa.12611. [PubMed: 24628379].
  • 17. Dargaville PA, Aiyappan A, De Paoli AG, Kuschel CA, Kamlin CO, Carlin JB, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed. 2013;98(2):122-6. doi: 10.1136/archdischild-2011-301314. [PubMed: 22684154].
  • 18. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2009;(2):7836. doi: 10.1002/14651858.CD007836. [PubMed: 19370695].
  • 19. Finer NN, Carlo WA, Duara S, Fanaroff AA, Donovan EF, Wright LL, et al. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics. 2004;114(3):651-7. doi: 10.1542/peds.2004-0394. [PubMed: 15342835].
  • 20. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics. 2010;125(6):1402-9. doi: 10.1542/peds.2009-2131. [PubMed: 20439601].
  • 21. Verder H, Agertoft L, Albertsen P, Christensen NC, Curstedt T, Ebbesen F, et al. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study]. Ugeskr Laeger. 1992;154(31):2136-9. [PubMed: 1509593].
  • 22. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013;131(2):502-9. doi: 10.1542/peds.2012-0603. [PubMed: 23359581].
  • 23. Kribs A, Pillekamp F, Hunseler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age Paediatr Anaesth. 2007;17(4):364-9. doi: 10.1111/j.1460-9592.2006.02126.x. [PubMed: 17359406].
  • 24. Al Ethawi Y. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. J Clin Neonatol. 2012;1(2):66-8. doi: 10.4103/2249-4847.96744. [PubMed: 24027691].
  • 25. Mirnia K, Heidarzadeh M, Hoseini MB, Sadeghnia A, Akrami F, Balila M, et al. Surfactant administration via thin catheter during spontaneous breathing, randomized controlled trial in Alzahra hospital. Iran J Neonatol. 2013;4(2):5-9. doi: 10.22038/ijn.2013.1075.
  • 26. Gopel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. The Lancet. 2011;378(9803):1627-34. doi: 10.1016/s0140-6736(11)60986-0.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments